Stockreport

Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical [Yahoo! Finance]

ONO PHARM CO UNSP/ADR  (OPHLY) 
NASDAQ:AMEX Investor Relations: ono.co.jp/eng/investor/index.html
PDF license and research agreement with Ono Pharmaceutical Co., Ltd. to utilize Scenic's Cell-Seq platform for the discovery of novel therapeutic targets. “This collaborat [Read more]